Envista Holdings Corporation (NYSE:NVST - Get Free Report) shares gapped up prior to trading on Friday following a stronger than expected earnings report. The stock had previously closed at $18.89, but opened at $20.24. Envista shares last traded at $20.49, with a volume of 1,111,160 shares traded.
The company reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.24 by $0.02. The company had revenue of $682.10 million during the quarter, compared to the consensus estimate of $638.21 million. Envista had a return on equity of 4.84% and a net margin of 2.11%. The company's quarterly revenue was up 7.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.11 EPS.
Analyst Ratings Changes
Several research analysts recently weighed in on NVST shares. Stifel Nicolaus upped their price target on Envista from $24.00 to $25.00 and gave the company a "buy" rating in a research report on Friday. Bank of America dropped their price target on Envista from $26.00 to $23.00 and set a "buy" rating on the stock in a research report on Tuesday, April 29th. Baird R W raised Envista from a "hold" rating to a "strong-buy" rating in a research report on Tuesday, May 27th. Mizuho upped their price target on Envista from $15.00 to $18.00 and gave the company an "underperform" rating in a research report on Friday. Finally, Wall Street Zen raised Envista from a "buy" rating to a "strong-buy" rating in a research report on Saturday. One research analyst has rated the stock with a sell rating, nine have given a hold rating, four have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $20.92.
View Our Latest Report on NVST
Institutional Investors Weigh In On Envista
A number of large investors have recently bought and sold shares of the business. Treasurer of the State of North Carolina grew its position in shares of Envista by 0.6% in the fourth quarter. Treasurer of the State of North Carolina now owns 75,560 shares of the company's stock valued at $1,458,000 after purchasing an additional 480 shares during the last quarter. Vanguard Personalized Indexing Management LLC lifted its stake in Envista by 5.6% during the second quarter. Vanguard Personalized Indexing Management LLC now owns 20,100 shares of the company's stock worth $393,000 after purchasing an additional 1,067 shares during the period. Palouse Capital Management Inc. grew its holdings in shares of Envista by 14.4% in the 1st quarter. Palouse Capital Management Inc. now owns 9,444 shares of the company's stock worth $163,000 after purchasing an additional 1,186 shares during the last quarter. California Public Employees Retirement System raised its stake in shares of Envista by 0.4% in the fourth quarter. California Public Employees Retirement System now owns 288,546 shares of the company's stock valued at $5,566,000 after acquiring an additional 1,272 shares during the last quarter. Finally, Parallel Advisors LLC raised its stake in shares of Envista by 100.1% in the second quarter. Parallel Advisors LLC now owns 2,792 shares of the company's stock valued at $55,000 after acquiring an additional 1,397 shares during the last quarter.
Envista Stock Down 2.0%
The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.08 and a current ratio of 2.44. The firm's 50-day moving average is $19.49 and its two-hundred day moving average is $18.61. The stock has a market cap of $3.33 billion, a P/E ratio of 62.70, a PEG ratio of 1.22 and a beta of 1.00.
Envista Company Profile
(
Get Free Report)
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Featured Stories
Before you consider Envista, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.
While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.